Jiangxi Chenyang Pharmaceutical Co. Ltd. was founded on march, 2008, and the factory was located in zone C, taiwan Industrial Park, Jinxi County, Fuzhou City, Jiangxi Province, China (Provincial Chemical Industrial Park), with a registrar capital of 70 million RMB. The company was occupied 40000 square meters, mainly committed to R&D, produce and sell pharmaceutical intermediates, APIs and other chemicals.
We have R&D laboratories, five workshops and one office building, and have complete sewage, exhaust gas treatment facilities, and also established a relatively complete quality management system. We have already passed the fire control acceptance and obtained the safety production license of hazardous chemicals and sewage discharge permission. We are the level 3 standardized enterprise for safety production, and have legal chemical production qualification.
Currently, the main products of our company produced are the followings:
1-cyclopropyl-6,7-difluoro-1,4-dihydhro-8-methoxy-4-oxo-3-quinolinecarboxylic acid-ethyl ester, 1-cyclopropyl-6,7-difluoro-1,4-dihydhro-8-methoxy-4-oxo-3-quinolinecarboxylic acid, Gatifloxacin, Gatiflocacin mesylate, Levofloxacin acid ester, Levofloxacin carboxylic acid, Lecofloxacin, Lecofloxacin hydrochloride, praziquantel, Sarafloxacin, sarafloxacin hydrochloride, Moxifloxacin hydrochloride, Dehydroisoandrosterone 3-acetate, (+)-Dehydroisoandrosterone 3-acetate, and so on.
To provide our customers with better products and service, we will always comply with our enterprise management policy: "keeping progressing with high-quality production and integrity management."
The develpment goal of our company is to become a manufacturer of pharmaceutical raw materials and intermediates with independent R&D capabilities and substantial productivity.